. 2018 Nov 8;13(11):e0207162. doi: 10.1371/journal.pone.0207162

Table 2. 25(OH)D3 serum levels in patients with advanced liver fibrosis/cirrhosis.

25(OH)D₃ serum levels (ng/mL)
Overall (N = 338)
25(OH)D₃ >30 ng/ml, N [%]	132 [39]
25(OH)D₃ 30–20 ng/ml, N [%]	61 [18]
25(OH)D₃ 20–10 ng/ml, N [%]	73 [22]
25(OH)D₃ <10 ng/ml, N [%]	72 [21]
Patients on vitamin D supplements (N = 118)
25(OH)D₃ >30 ng/ml, N [%]	84 [71]
25(OH)D₃ 30–20 ng/ml, N [%]	24 [20]
25(OH)D₃ 20–10 ng/ml, N [%]	7 [6]
25(OH)D₃ <10 ng/ml, N [%]	3 [3]
Patients without vitamin D supplements (N = 220)
25(OH)D₃ >30 ng/ml N; [%]	48 [22]
25(OH)D₃ 30–20 ng/ml N; [%]	37 [17]
25(OH)D₃ 20–10 ng/ml N; [%]	66 [30]
25(OH)D₃ <10 ng/ml N; [%]	69 [31]